Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Change in Accured Expenses: 2023-2025

Historic Change in Accured Expenses for Camp4 Therapeutics (CAMP) over the last 2 years, with Sep 2025 value amounting to $1.4 million.

  • Camp4 Therapeutics' Change in Accured Expenses rose 89.96% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 474.60%. This contributed to the annual value of $1.5 million for FY2024, which is 1225.74% up from last year.
  • As of Q3 2025, Camp4 Therapeutics' Change in Accured Expenses stood at $1.4 million, which was up 32.10% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Change in Accured Expenses ranged from a high of $1.8 million in Q4 2024 and a low of -$2.8 million during Q1 2025.
  • Over the past 3 years, Camp4 Therapeutics' median Change in Accured Expenses value was $639,500 (recorded in 2023), while the average stood at $212,500.
  • Per our database at Business Quant, Camp4 Therapeutics' Change in Accured Expenses skyrocketed by 227.58% in 2024 and then crashed by 721.88% in 2025.
  • Quarterly analysis of 3 years shows Camp4 Therapeutics' Change in Accured Expenses stood at $562,000 in 2023, then surged by 227.58% to $1.8 million in 2024, then surged by 89.96% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, $1.0 million for Q2 2025, and -$2.8 million during Q1 2025.